Name
III.14 - Evaluation of a 12-Week Allopurinol-Lowering Therapy in Combination with the Non-Steroidal Anti-Inflammatory Drug Meloxicam in Patients with Chronic Gout
Date & Time
Monday, October 18, 2021
Speakers